Edition:
United States

Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

27.25USD
14 Dec 2017
Change (% chg)

$-1.30 (-4.55%)
Prev Close
$28.55
Open
$28.70
Day's High
$28.90
Day's Low
$27.00
Volume
186,760
Avg. Vol
488,515
52-wk High
$30.45
52-wk Low
$16.75

Chart for

About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $1,578.76
Shares Outstanding(Mil.): 55.30
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.13 15.47
EPS (TTM): -- -- --
ROI: -- 10.01 33.71
ROE: -- 15.22 16.38

BRIEF-Accelerate Diagnostics says ‍on Nov 14, board increased its size to 8 members​

* Accelerate Diagnostics says ‍on Nov 14, board increased size of board to 8 members​ - SEC Filing Source text: [http://bit.ly/2iocMIO] Further company coverage:

Nov 16 2017

BRIEF-Accelerate Diagnostics reports Q3 loss per share $0.31

* Accelerate Diagnostics Inc reports q3 2017 financial results

Nov 02 2017

BRIEF-Plaintiffs dismiss class action appeal against Accelerate Diagnostics

* Plaintiffs dismiss class action appeal against Accelerate Diagnostics

Sep 13 2017

BRIEF-Accelerate Diagnostics reports Q2 loss per share $0.31

* Accelerate Diagnostics reports Q2 2017 financial results, doubles revenue generating placements

Aug 03 2017

Earnings vs. Estimates